跳至主要内容
临床试验/ISRCTN23993517
ISRCTN23993517已完成不适用

Study to investigate the nutritional efficacy and Acceptance/Tolerance characteristics Of an extensively hydrolyzed whey protein formula with added Synbiotics in infants (ATOS)

Danone Research B.V. (The Netherlands)0 个研究点目标入组 228 人开始时间: 2012年12月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
228

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Healthy term infants (gestational age 37- 42 weeks)
  • 2. 0-35 days of age
  • 3. Normal birth weight dependent on gender, and week of delivery
  • 4. Exclusively formula fed
  • 5. Written informed consent by both parents

排除标准

  • 1. Infants with the following allergic symptoms:
  • 1.1. Atopic dermatitis prior to inclusion, according to the Hanifin criteria
  • 1.2. Wheezing
  • 2. Previous use of antibiotics and therapeutic blood components by infant prior to inclusion
  • 3. Previous use of antibiotics by the mother during breastfeeding prior to inclusion
  • 4. Infants with congenital abnormality or chromosomal disorder disease (such as cystic fibrosis, tuberculosis, bronchopulmonary dysplasia, tracheomalacia, tracheoesophageal fistula, major congenital heart disease, down?s syndrome)
  • 5. Parental history and pre- or perinatal indications for inherited immunodeficiency syndromes.
  • 6. Infants with congenital infections (Group B streptococcal disease, Hepatitis B, Toxoplasmose, Rubella, herpes, syphillis, Epstein Bar)
  • 7. Infants requiring intubations or mechanical ventilation
  • 8. Infants of mothers with a significant illness or disability

研究者

发起方
Danone Research B.V. (The Netherlands)

相似试验